KS Biomedix Holdings plc, of London, appointed Ian Miscampbell as chief operating officer.
Magainin Pharmaceuticals Inc., of Plymouth Meeting, Pa., placed Michael Zasloff in the newly created position of scientific consultant to the company. He will continue to serve on the board of directors.
Maxim Pharmaceuticals Inc., of San Diego, said William Poncy joined the company as senior director, U.S. sales, and Dennis Takasugi joined as senior director, marketing.
Medicure Inc., of Winnipeg, Manitoba, named Raymond Gibbons to its scientific advisory board.
NovaScreen Biosciences Corp., of Hanover, Md., elected Melvin Booth to its board of directors. Booth is president and chief operating officer of MedImmune Inc.
Pharmadigm Inc., of Salt Lake City, named Ned Weinshenker CEO and president of the company.
PowderJect Pharmaceuticals plc, of Oxford, UK, named Gerald Moller a non-executive director.
Regeneron Pharmaceuticals Inc., of Tarrytown, N.Y., said Stuart Kolinski joined the company as vice president, general counsel and secretary.
Sicor Inc., of Irvine, Calif., elected Marvin Samson to its board of directors.
The Council for Biotechnology Information, of Washington, said Linda Thrane accepted the position of executive director.
Zila Inc., of Phoenix, named David Hurwitz vice president and general manager of its consumer pharmaceuticals division.